Lowland says that, over the 12 months ended 30 September 2022, its NAV total return was -14.8% and the return to shareholders was -16.4%, which compares with a return of -4.0% for the All-Share over that period. The annual dividend was upped from 6.025p to 6.1p, double the dividend 10 years earlier. Lowland’s investment policy […]
In QuotedData’s morning briefing 13 December 2022: HgCapital Trust (HGT) is selling its stake in Transporeon, a leading cloud-based logistics and transportation management software platform, to Trimble as part of a transaction that values the whole of that business at an enterprise value of €1.88bn. The trust’s share of the proceeds is about £107.8m. The […]
RTW Venture Fund has drawn investors’ attention to positive data updates on two clinical trials of Prometheus Biosciences, Inc. (NASDAQ: RXDX), its third largest holding, representing about 7.5% of NAV. Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for […]
RTW was a co-lead in a $149m Series B financing round for Apogee Therapeutics, LLC, a biotechnology company focused on immunological and inflammatory disorders. RTW Venture participated in the fundraise but we have not been not told what its contribution was. Proceeds from the financing will be used to support Apogee’s plans to advance its […]
VH Global Sustainable Energy Opportunities has completed its purchase of the Mascarenhas Hydro Electric Facility in the state of Espírito Santo, Brazil. The final amount paid on completion was BRL 708m (the headline BRL 800m previously announced was subject to adjustments based on the latest balance sheet related to agreed cash and working capital levels). The […]
Finsbury Growth and Income lagged the return on its All-Share index benchmark over the 12 months ended 30 September 2022, returning -5.8% to the index’s -4.0%. The return to shareholders was -5.6%. This follows on from more significant underperformance in the prior accounting year. £76m worth of shares were bought back in an effort to […]
BlackRock Frontier Markets underperformed its benchmark over the 12 months ended 30 September 2022, returning -10.9% to the benchmark’s -7.3% (in US dollar terms – in sterling the figures were +7.7% versus +12.0%). The benchmark is a complex beast (MSCI Emerging Markets Index ex Selected Countries + MSCI Frontier Markets Index + MSCI Saudi Arabia […]
Barings Emerging EMEA Opportunities saw a -29.9% NAV total return for the 12 months ended 30 September 2022. Its performance benchmark return was -20.1%. The dividend was reduced by 9p to 17p. The company’s investments in Russia, now valued at zero, were responsible for the vast majority of the absolute decline in net asset value […]
Henderson European Focus more or less matched the fall in its World Europe ex UK index benchmark over the 12 months ended 30 September 2022, returning -13.1% to the index’s -12.8%. However, a widening discount left investors with a share price return of -18.3%. Fortunately, the closing share price at 6 December 2022 was 149p, […]
In QuotedData’s morning briefing 8 December 2022: Hipgnosis Songs (SONG) has published its interim accounts. Net cash generated from operating activities rose by 6.9% to $45.5m, but the interest paid rose to $15.0m from $10.7m and the fund incurred additional borrowing costs of $6.2m as it fixed the cost of its debt. A weaker US […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
